This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts’ Opinions Are Mixed on These Financial Stocks: Upstart Holdings (UPST) and Renaissancere Holdings (RNR)

Tipranks - Wed Jul 8, 7:02AM CDT

Companies in the Financial sector have received a lot of coverage today as analysts weigh in on Upstart Holdings (UPST) and Renaissancere Holdings (RNR).

4th of July Sale - 70% Off

Upstart Holdings (UPST)

Truist Financial analyst Arvind Ramnani maintained a Buy rating on Upstart Holdings today. The company’s shares closed last Monday at $34.33.

According to TipRanks.com, Ramnani is a 1-star analyst with an average return of -1.8% and a 47.0% success rate. Ramnani covers the Technology sector, focusing on stocks such as CCC Intelligent Solutions Holdings, Palantir Technologies, and Epam Systems. ;'>

Currently, the analyst consensus on Upstart Holdings is a Moderate Buy with an average price target of $37.33, implying a 7.4% upside from current levels. In a report issued on June 30, BTIG also maintained a Buy rating on the stock with a $43.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

Renaissancere Holdings (RNR)

In a report released yesterday, Tyler Van Buren from TD Cowen maintained a Hold rating on Renaissancere Holdings, with a price target of $315.00. The company’s shares closed last Monday at $323.11.

According to TipRanks.com, Buren is a top 100 analyst with an average return of 35.4% and a 61.1% success rate. Buren covers the Healthcare sector, focusing on stocks such as Artiva Biotherapeutics, Inc., NewAmsterdam Pharma Company, and Odyssey Therapeutics, Inc. ;'>

Currently, the analyst consensus on Renaissancere Holdings is a Moderate Buy with an average price target of $332.27, representing a 2.0% upside. In a report issued on July 4, TipRanks – Anthropic also downgraded the stock to Hold with a $356.00 price target.

Read More on UPST:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.